| scholarly article | Q13442814 |
| P356 | DOI | 10.7326/0003-4819-77-6-861 |
| P698 | PubMed publication ID | 4118759 |
| P2093 | author name string | C Young | |
| J R Smith | |||
| A Yagoda | |||
| B Mukherji | |||
| C T Tan | |||
| I H Krakoff | |||
| E Etcubanas | |||
| C Lamonte | |||
| P433 | issue | 6 | |
| P304 | page(s) | 861-870 | |
| P577 | publication date | 1972-12-01 | |
| P1433 | published in | Annals of Internal Medicine | Q564416 |
| P1476 | title | Bleomycin, an antitumor antibiotic. Clinical experience in 274 patients | |
| P478 | volume | 77 |
| Q39359767 | 67Ga accumulation in pulmonary lesions associated with bleomycin toxicity |
| Q37000477 | A fatal hyperpyrexial response to bleomycin following prior therapy: a case report and literature review |
| Q72607584 | A trial of outpatient chemotherapy for recurrent head and neck tumors |
| Q33476057 | Acute Bleomycin and Methotrexate Toxicity: Report of Two Cases |
| Q36571909 | Acute Pericarditis Following Bleomycin: A Case Report and Literature Analysis |
| Q90644344 | Acute liver failure secondary to ABVD use |
| Q39525107 | Adriamycin, bleomycin, and CCNU as effective induction chemotherapeutic agents in advanced squamous cell carcinoma (COG protocol 7333) |
| Q33372376 | Assessment of pulmonary and hematologic toxicities of liblomycin, a novel bleomycin analog |
| Q72709463 | Bleomycin in the treatment of recalcitrant warts |
| Q42651732 | Bleomycin induced urethral stricture in Hodgkin's disease |
| Q38537946 | Bleomycin pharmacokinetics in man. I. Intravenous administration |
| Q72748756 | Bleomycin pulmonary toxicity: Its relationship to renal dysfunction |
| Q37049708 | Bleomycin-induced diffuse interstitial pulmonary fibrosis in baboons |
| Q40837853 | Bleomycin-induced fatal hyperpyrexia |
| Q55692043 | Bleomycin-induced flagellate dermatitis. |
| Q39525128 | Bleomycin-induced lung injury in baboons: Alteration of cells and immunoglobulins recoverable by bronchoalveolar lavage |
| Q72626565 | Bleomycin-induced pulmonary fibrosis mimicking recurrent metastatic disease in a patient with testicular carcinoma: Case report of the CT scan appearance |
| Q35570990 | Bleomycin-induced pulmonary toxicity in chemotherapy for testicular cancer |
| Q33163524 | Brentuximab vedotin combined with ABVD or AVD for patients with newly diagnosed Hodgkin's lymphoma: a phase 1, open-label, dose-escalation study |
| Q26766294 | Challenges and Current Efforts in the Development of Biomarkers for Chronic Inflammatory and Remodeling Conditions of the Lungs |
| Q66704754 | Chemotherapy of head and neck cancer |
| Q40076021 | Chemotherapy strategies in squamous cell carcinoma of the head and neck |
| Q72613836 | Chromatographic separation of endotoxin and bleomycin for pyrogenicity testing |
| Q45893466 | Cis-diamminedichloride platinum II (DDP) in the treatment of penile carcinoma |
| Q72670047 | Clinical Pharmacology of Bleomycin and Cisplatin |
| Q40101938 | Clinical pharmacology of bleomycin and cisplatin |
| Q40667480 | Combination Chemotherapy of Advanced Squamous Carcinoma of the Head and Neck |
| Q54508459 | Combination chemotherapy of refractory lymphoma with cis-dichlorodiamineplatinum, vinblastine, and bleomycin |
| Q39356901 | Combination therapy for advanced resistant Hodgkin's disease |
| Q39408184 | Combined treatment with radiation and bleomycin for intra-oral carcinoma. A preliminary report |
| Q37853021 | Complications associated with chemotherapy in testicular cancer management |
| Q40075627 | Cutaneous T-cell lymphoma: A review |
| Q71105091 | Cutaneous complications of chemotherapeutic agents |
| Q39430832 | Cytotoxic drug-induced lung disease |
| Q34005812 | Drug-induced respiratory disorders: incidence, prevention and management |
| Q34965874 | Effect of Bleomycin on Deoxyribonucleic Acid Synthesis in Toluene-Treated Escherichia coli Cells |
| Q72615873 | Effect of a bleomycin derivative on oral carcinoma. A clinical and immunologic study of five cases |
| Q70755913 | Effectiveness of once weekly total skin electron beam therapy in mycosis fungoides and sezary syndrome |
| Q72664122 | Evaluation of Lung Ventilation and Carbon Monoxide-Diffusing Capacity in Patients with Nonseminomatous Testicular Tumors Treated with Bleomycin |
| Q39591596 | Fatal interstitial pneumonitis induced by low dosage of bleomycin in an esophageal cancer patient |
| Q83343790 | Flagellate erythema |
| Q68945507 | Flagellate pigmentation from intrapleural bleomycin. A light microscopy and electron microscopy study |
| Q28336334 | Hemolytic uremic syndrome in a patient on cis-platinum, vinblastine and bleomycin |
| Q26861560 | Hepatotoxicity Secondary to Chemotherapy |
| Q39371278 | High dose intravenous bleomycin in the treatment of advanced lymphomas |
| Q72072250 | Hyperpigmentation in striae distensae after bleomycin treatment |
| Q72735645 | Idiosyncratic reaction to bleomycin in an epithelial tumor |
| Q39414778 | Intraarterial bleomycin therapy on squamous cell carcinomas of the oral cavity. Clinico-pathological investigations (author's transl) |
| Q35187360 | Long-term complications of chemotherapy for germ cell tumours |
| Q30486885 | Long-term toxicity of chemotherapy for testicular cancer--the cost of cure |
| Q40097623 | Lung damage from cytotoxic drugs |
| Q40715751 | Metastatic Carcinoma Of The Penis: Complete Remissionafter High Dose Methotrexate Chemotherapy |
| Q38610456 | Modeling DNA damage-induced pneumopathy in mice: insight from danger signaling cascades |
| Q39785103 | Mucocutaneous side effects of cancer chemotherapy |
| Q39394805 | Multiple agent chemotherapy for advanced histiocytic lymphoma |
| Q36484579 | Nail changes caused by systemic drugs or ingestants. |
| Q36601510 | Nail changes secondary to systemic drugs or ingestants |
| Q52105169 | Neuropsychiatric effects of chemotherapeutic agents for cancer. |
| Q39403190 | New multiple-agent chemotherapy (B-DOPA) for advanced Hodgkin's disease |
| Q72720181 | Pharmacokinetics of Anticancer Drugs in Children |
| Q39768346 | Pharmacokinetics of anticancer drugs in children |
| Q39427124 | Phase I–II trial of intramuscularly administered bleomycin |
| Q46210414 | Prevention of bleomycin-induced fibrosing alveolitis with indomethacin: Stereological studies on rat lungs |
| Q72680752 | Pulmonary Pseudotumours Following Chemotherapy for Endodermal Sinus Tumour of the Ovary |
| Q39462731 | Pulmonary reactions to drugs |
| Q34051251 | Pulmonary toxicity of antineoplastic agents |
| Q67700850 | Pulmonary toxicity of the combination of bleomycin and peplomycin ? an experimental study in rats |
| Q66844532 | Re-Exploration for Retroperitoneal Lymph Node Metastases from Testis Tumors |
| Q72616428 | Regression of juvenile laryngobronchial papillomatosis with systemic bleomycin therapy |
| Q40097510 | Role of chemotherapy in head and neck cancer: systemic use of single agents and combinations in advanced disease |
| Q88230175 | Testicular Cancer: Risk Factors and the Role of Adjuvant Chemotherapy |
| Q77318402 | Testicular cancer |
| Q72076258 | Testicular cancer and Hodgkin disease in the same patient |
| Q39542491 | The clinical evaluation of analogues II. Bleomycins |
| Q39360989 | The effects of intra-arterial bleomycin therapy on squamous cell carcinoma of the oral cavity. Biopsy and autopsy examinations |
| Q34979641 | The hepoxilins and some analogues: a review of their biology |
| Q72741940 | The treatment of resistant warts with intralesional bleomycin: a controlled clinical trial |
| Q39340957 | Toxic lesions of the hand associated with chemotherapy |
| Q39843788 | Treatment of cutaneous T-cell lymphoma. |
| Q39519853 | Ultrastructural study of bleomycin-induced pulmonary changes in mice |
| Q39744008 | Update in cancer chemotherapy: gastrointestinal cancer, cancer of the small intestines, gallbladder, liver, and esophagus |
| Q69401126 | Upper extremity injuries due to medications |
| Q41679978 | Vascular sclerosing effects of bleomycin on cutaneous veins: a pharmacopathologic study on experimental animals |
Search more.